3.87
-0.06 (-1.53%)
| Previous Close | 3.93 |
| Open | 3.96 |
| Volume | 24,629 |
| Avg. Volume (3M) | 63,413 |
| Market Cap | 774,508,992 |
| Price / Sales | 20.16 |
| Price / Book | 22.57 |
| 52 Weeks Range | |
| Earnings Date | 14 May 2026 |
| Profit Margin | -67.73% |
| Operating Margin (TTM) | -115.65% |
| Diluted EPS (TTM) | -0.080 |
| Quarterly Revenue Growth (YOY) | 40.80% |
| Total Debt/Equity (MRQ) | 25.78% |
| Current Ratio (MRQ) | 3.17 |
| Operating Cash Flow (TTM) | -12.93 M |
| Levered Free Cash Flow (TTM) | -14.06 M |
| Return on Assets (TTM) | -19.93% |
| Return on Equity (TTM) | -55.43% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | SS Innovations International In | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 1.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | 0.38 |
|
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Mid Growth |
| % Held by Insiders | 83.38% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Forum Financial Management, Lp | 31 Mar 2026 | 38,469 |
| Alti Global, Inc. | 31 Mar 2026 | 20,555 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |